Renal basement membrane components

Kidney International

Volumn 56, Issue 6, 1999, Pages 2016-2024

  Miner, Jeffrey H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Collagen; Entactin; Extracellular matrix; Glomerular basement membrane; Kidney disease; Laminin; Tubular basement membrane

Indexed keywords

AGRIN; COLLAGEN TYPE 4; ENTACTIN; KALININ; LAMININ; MEROSIN; PERLECAN; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN;

DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; GENE MUTATION; GLOMERULUS BASEMENT MEMBRANE; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; KIDNEY EPITHELIUM; MEMBRANE COMPONENT; MESANGIUM; NEPHRON; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW;

EID: 0033460287     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00785.x     Document Type: Article

References (120)

1. 1. Timpl R: Structure and biological activity of basement membrane proteins. Eur J Biochem 180:487-502, 1989
2. 2. Paulsson M: Basement membrane proteins: Structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 27:93-127, 1992
3. 3. Yurchenco PD, O'Rear JJ: Basal lamina assembly. Curr Opin Cell Biol 6:674-681, 1994
4. 4. Timpl R: Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618-624, 1996
5. 5. Timpl R, Brown JC: Supramolecular assembly of basement membranes. Bioessays 18:123-132, 1996
6. 6. Timpl R, Brown JC: The laminins. Matrix Biol 14:275-281, 1994
7. 7. Delwel GO, Sonnenberg A: Laminin isoforms and their integrin receptors, in Adhesion Receptors as Therapeutic Targets, edited by Horton MA, Boca Raton, CRC Press, Inc., 1996, pp 9-36
8. 8. Engvall E, Wewer UM: Domains of laminin. J Cell Biochem 61:493-501, 1996
9. 9. Malinda KM, Kleinman HK: The laminins. Int J Biochem Cell Biol 28:957-959, 1996
10. 10. Ryan MC, Christiano AM, Engvall E, Wewer UM, Miner JH, Sanes JR, Burgeson RE: The functions of laminins: Lessons from in vivo studies. Matrix Biol 15:369-381, 1996
11. 11. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR: Laminin: A glycoprotein from basement membranes. J Biol Chem 254:9933-9937, 1979
12. 12. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, Martin GR, Ortonne J-P, Paulsson M, Sanes J, Timpl R, Tryggvason K, Yamada Y, Yurchenco PD: A new nomenclature for laminins. Matrix Biol 14:209-211, 1994
13. 13. Beck K, Hunter I, Engel J: Structure and function of laminin: Anatomy of a multidomain glycoprotein. FASEB J 4:148-160, 1990
14. 14. Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR: Distribution and isolation of four laminin variants: Tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1:731-740, 1990
15. 15. Rousselle P, Lunstrum GP, Keene DR, Burgeson RE: Kalinin: An epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 114:567-576, 1991
16. 16. Marinkovich MP, Lunstrum GP, Keene DR, Burgeson RE: The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 119:695-703, 1992
17. 17. Champliaud MF, Lunstrum GP, Rousselle P, Nishiyama T, Keene DR, Burgeson RE: Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol 132:1189-1198, 1996
18. 18. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG, Sanes JR: The laminin α chains: Expression, developmental transitions, and chromosomal locations of α1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel α3 isoform. J Cell Biol 137:685-701, 1997
19. 19. Koch M, Olson PF, Albus A, Jin W, Hunter DD, Brunken WJ, Burgeson RE, Champliaud MF: Characterization and expression of the laminin gamma3 chain: A novel, non-basement membrane-associated, laminin chain. J Cell Biol 145:605-618, 1999
20. 20. Lindblom A, Marsh T, Fauser C, Engel J, Paulsson M: Characterization of native laminin from bovine kidney and comparison with other laminin variants. Eur J Biochem 219:383-392, 1994
21. 21. Sorokin LM, Conzelmann S, Ekblom P, Battaglia C, Aumailley M, Timpl R: Monoclonal antibodies against laminin A chain fragment E3 and their effects on binding to cells and proteoglycan and on kidney development. Exp Cell Res 201:137-144, 1992
22. 22. Sorokin LM, Pausch F, Durbeej M, Ekblom P: Differential expression of five laminin α(1-5) chains in developing and adult mouse kidney. Dev Dyn 210:446-462, 1997
23. 23. Klein G, Langegger M, Timpl R, Ekblom P: Role of laminin A chain in the development of epithelial cell polarity. Cell 55:331-341, 1988
24. 24. Sanes JR, Engvall E, Butkowski R, Hunter DD: Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 111:1685-1699, 1990
25. 25. Miner JH, Sanes JR: Collagen IV α3, α4, and α5 chains in rodent basal laminae: Sequence, distribution, association with laminins, and developmental switches. J Cell Biol 127:879-891, 1994
26. 26. Xu H, Wu X-R, Wewer UM, Engvall E: Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat Genet 8:297-302, 1994
27. 27. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tome FM, Schwartz K, Fardeau M, Tryggvason K: Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 11:216-218, 1995
28. 28. Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahata K, Takeda S: Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: A new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 415:33-39, 1997
29. 29. Miner JH: Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 7:13-19, 1998
30. 30. Durbeej M, Fecker L, Hjalt T, Zhang H-Y, Salmivirta K, Klein G, Timpl R, Sorokin L, Ebendal T, Ekblom P, Ekblom M: Expression of laminin α1, α5 and β2 chains during embryogenesis of the kidney and vasculature. Matrix Biol 15:397-413, 1996
31. 31. Tiger C-F, Champliaud M-F, Pedrosa-Domellof F, Thornell L-E, Ekblom P, Gullberg D: Presence of laminin α5 chain and lack of laminin α1 chain during human muscle development and in muscular dystrophies. J Biol Chem 272:28590-28595, 1997
32. 32. Aberdam D, Aguzzi A, Baudoin C, Galliano MF, Ortonne JP, Meneguzzi G: Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles. Cell Adhes Commun 2:115-129, 1994
33. 33. Sugiyama S, Utani A, Yamada S, Kozak CA, Yamada Y: Cloning and expression of the mouse laminin gamma 2 (B2t) chain, a subunit of epithelial cell laminin. Eur J Biochem 228:120-128, 1995
34. 34. Mizushima H, Koshikawa N, Moriyama K, Takamura H, Nagashima Y, Hirahara F, Miyazaki K: Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues. Horm Res 50:7-14, 1998
35. 35. Aberdam D, Galliano MF, Vailly J, Pulkkinen L, Bonifas J, Christiano AM, Tryggvason K, Uitto J, Epstein EH Jr, Ortonne JP, Meneguzzi G: Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet 6:299-304, 1994
36. 36. Pulkkinen L, Christiano AM, Airenne T, Haakana H, Tryggvason K, Uitto J: Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet 6:293-298, 1994
37. 37. Pulkkinen L, Christiano AM, Gerecke D, Wagman DW, Burgeson RE, Pittelkow MR, Uitto J: A homozygous nonsense mutation in the β3 gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 24:357-360, 1994
38. 38. McGrath JA, Kivirikko S, Ciatti S, Moss C, Dunnill GS, Eady RA, Rodeck CH, Christiano AM, Uitto J: A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in Herlitz junctional epidermolysis bullosa: Prenatal exclusion in a fetus at risk. Genomics 29:282-284, 1995
39. 39. Kuster JE, Guarnieri MH, Ault JG, Flaherty L, Swiatek PJ: IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. Mamm Genome 8:673-681, 1997
40. 40. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP: The renal glomerulus of mice lacking s-laminin/ laminin β2: Nephrosis despite molecular compensation by laminin β1. Nat Genet 10:400-406, 1995
41. 41. Ekblom M, Klein G, Mugrauer G, Fecker L, Deutzmann R, Timpl R, Ekblom P: Transient and locally restricted expression of laminin A chain mRNA by developing epithelial cells during kidney organogenesis. Cell 60:337-346, 1990
42. 42. Miner JH, Cunningham J, Sanes JR: Roles for laminin in embryogenesis: Exencephaly, syndactyly, and placentopathy in mice lacking the laminin α5 chain. J Cell Biol 143:1713-1723, 1998
43. 43. Iivanainen A, Morita T, Tryggvason K: Molecular cloning and tissue-specific expression of a novel murine laminin gamma 3 chain. J Biol Chem 274:14107-14111, 1999
44. 44. Hudson BG, Wieslander J, Wisdom BJ Jr, Noelken ME: Biology of disease: Goodpasture syndrome: Molecular architecture and function of basement membrane antigen. Lab Invest 61:256-269, 1989
45. 45. Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: Structure, gene organization, and role in human diseases. J Biol Chem 268:26033-26036, 1993
46. 46. Kuhn K: Basement membrane (type IV) collagen. Matrix Biol 14:439-445, 1994
47. 47. Pihlajaniemi T: Molecular properties of the glomerular basement membrane. Contrib Nephrol 117:46-79, 1996
48. 48. Wisdom BJ Jr, Gunwar S, Hudson MD, Noelken ME, Hudson BG: Type IV collagen of Engelbreth-Holm-Swarm tumor matrix: Identification of constituent chains. Connect Tissue Res 27:225-234, 1992
49. 49. Kleppel MM, Santi PA, Cameron JD, Wieslander J, Michael AF: Human tissue distribution of novel basement membrane collagen. Am J Pathol 134:813-825, 1989
50. 50. Hostikka SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB, Tryggvason K: Identification of a distinct type IV collagen a chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 87:1606-1610, 1990
51. 51. Kleppel MM, Fan WW, Cheong HI, Kashtan CE, Michael AF: Immunochemical studies of the Alport antigen. Kidney Int 41:1629-1637, 1992
52. 52. Lohi J, Korhonen M, Leivo I, Kangas L, Tani T, Kalluri R, Miner JH, Lehto V-P, Virtanen I: Expression of type IV collagen α1(IV)-α6(IV) polypeptides in normal and developing human kidney and in renal cell carcinomas and oncocytomas. Int J Cancer 72:43-49, 1997
53. 53. Kleppel MM, Fan WW, Cheong HI, Michael AF: Evidence for separate networks of classical and novel basement membrane collagen: Characterization of α3(IV)-Alport antigen heterodimer. J Biol Chem 267:4137-4142, 1992
54. 54. Kahsai TZ, Enders GC, Gunwar S, Brunmark C, Wieslander J, Kalluri R, Zhou J, Noelken ME, Hudson BG: Seminiferous tubule basement membrane: Composition and organization of type IV collagen chains, and the linkage of α3(IV) and α5(IV) chains. J Biol Chem 272:17023-17032, 1997
55. 55. Gunwar S, Ballester F, Noelken ME, Sado Y, Ninomiya Y, Hudson BG: Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J Biol Chem 273:8767-8775, 1998
56. 56. Desjardins M, Gros F, Wieslander J, Gubler M-C, Bendayan M: Heterogeneous distribution of monomeric elements from the globular domain (NCI) of type IV collagen in renal basement membranes as revealed by high resolution quantitative immunocytochemistry. Lab Invest 63:637-646, 1990
57. 57. Butkowski RJ, Wieslander J, Kleppel M, Michael AF, Fish AJ: Basement membrane collagen in the kidney: Regional localization of novel chains related to collagen IV. Kidney Int 35:1195-1202, 1989
58. 58. Ninomiya Y, Kagawa M, Iyama K, Naito I, Kishiro Y, Seyer JM, Sugimoto M, Oohashi T, Sado Y: Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 130:1219-1229, 1995
59. 59. Peissel B, Gene L, Kalluri R, Kashtan C, Rennke HG, Gallo GR, Yoshioka K, Sun MJ, Hudson BG, Neilson EG, Zhou J: Comparative distribution of the α1(IV), α5(IV), and α6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest 96:1948-1957, 1995
60. 60. Tryggvason K, Zhou J, Hostikka SL, Shows TB: Molecular genetics of Alport syndrome. Kidney Int 43:38-44, 1993
61. 61. Antignac C: Molecular genetics of basement membranes: The paradigm of Alport syndrome. Kidney Int 47(Suppl 49):S29-S33, 1995
62. 62. Lemmink HH, Schroder CH, Monnens LA, Smeets HJ: The clinical spectrum of type IV collagen mutations. Hum Mutat 9: 77-499, 1997
63. 63. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990
64. 64. Lemmink HH, Mochizuki T, van den Heuvel PWJ, Schroder CH, Barrientos A, Monnens LAH, van Oost BA, Brunner HG, Reeders ST, Smeets HJM: Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3:1269-1273, 1994
65. 65. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler M-C, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ, Reeders ST: Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77-82, 1994
66. 66. Zheng K, Thorner PS, Marrano P, Baumal R, McInnes RR: Canine X chromosome-linked hereditary nephritis: A genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV. Proc Natl Acad Sci USA 91:3989-3993, 1994
67. 67. Miner JH, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome. J Cell Biol 135:1403-1413, 1996
68. 68. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 10:2981-2992, 1996
69. 69. Lemmink HH, Nillesen WN, Mochizuki T, Schroder CH, Brunner HG, van Oost BA, Monnens LAH, Smeets HJM: Benign familial hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 98:1114-1118, 1996
70. 70. Jefferson JA, Lemmink HH, Hughes AE, Hill CM, Smeets HJ, Doherty CC, Maxwell AP: Autosomal dominant Alport syndrome linked to the type IV collagen alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 12:1595-1599, 1997
71. 71. Kashtan CE, Kleppel MM, Butkowski RJ, Michael AF, Fish AJ: Alport syndrome, basement membranes and collagen. Pediatr Nephrol 4:523-532, 1990
72. 72. Thorner PS, Zheng K, Kalluri R, Jacobs R, Hudson BG: Coordinate gene expression of the α3, α4, and α5 chains of collagen type IV: Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. J Biol Chem 271:13821-13828, 1996
73. 73. Nakanishi K, Yoshikawa N, Iijima K, Nakamura H: Expression of type IV collagen α3 and α4 chain mRNA in X-linked Alport syndrome. J Am Soc Nephrol 7:938-945, 1996
74. 74. Kashtan CE, Kim Y: Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42:115-126, 1992
75. 75. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y: Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 46:1413-1421, 1994
76. 76. Gubler M-C, Knebelmann B, Beziau A, Broyer M, Pirson Y, Haddoum F, Kleppel MM, Antignac C: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142-1147, 1995
77. 77. Kalluri R, Shield CF III, Todd P, Hudson BG, Neilson EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99:2470-2478, 1997
78. 78. Butkowski RJ, Langveld JPM, Wieslander J, Hamilton J, Hudson BG: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 262:7874-7877, 1987
79. 79. Saus J, Wieslander J, Langeveld JPM, Quinones S, Hudson BG: Identification of the Goodpasture antigen as the α3(IV) chain of collagen IV. J Biol Chem 263:13374-13380, 1988
80. 80. Kalluri R, Gunwar S, Reeders ST, Morrison KC, Mariyama M, Ebner KE, Noelken ME, Hudson BG: Goodpasture syndrome: Localization of the epitope for the autoantibodies to the carboxylterminal region of the α3(IV) chain of basement membrane collagen. J Biol Chem 266:24018-24024, 1991
81. 81. Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A, Pusey CD: Molecular cloning of the human Goodpasture antigen demonstrates it to be the α3 chain of type IV collagen. J Clin Invest 89:592-601, 1992
82. 82. Kalluri R, Sun MJ, Hudson BG, Neilson EG: The Goodpasture autoantigen: Structural delineation of two immunologically privileged epitopes on α3(IV) chain of type IV collagen. J Biol Chem 271:9062-9068, 1996
83. 83. Hudson BG, Kalluri R, Gunwar S, Weber M, Ballester F, Hudson JK, Noelken ME, Sarras M, Richardson WR, Saus J, Abrahamson DR, Glick AD, Haralson MA, Helderman JH, Stone WJ, Jacobson HR: The pathogenesis of Alport syndrome involves type IV collagen molecules containing the α3(IV) chain: Evidence from anti-GBM nephritis after renal transplantation. Kidney Int 42:179-187, 1992
84. 84. Kalluri R, Weber M, Netzer KO, Sun MJ, Neilson EG, Hudson BG: COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 45:721-726, 1994
85. 85. Kalluri R, van den Heuvel LP, Smeets HJM, Schroder CH, Lemmink HH, Boutaud A, Neilson EG, Hudson BG: A COL4A3 gene mutation and post-transplant anti-α3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 47:1199-1204, 1995
86. 86. Dehan P, van den Heuvel LPWJ, Smeets HJM, Tryggvason K, Foidart J-M: Identification of post-transplant anti-α5(IV) collagen alloantibodies in X-linked Alport syndrome. Nephrol Dial Transplant 11:1983-1988, 1996
87. 87. Brainwood D, Kashtan C, Gubler MC, Turner AN: Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53:762-766, 1998
88. 88. Chung AE, Durkin ME: Entactin: Structure and function. Am J Respir Cell Mol Biol 3:275-282, 1990
89. 89. Mayer U, Nischt R, Poschl E, Mann K, Fukuda K, Gerl M, Yamada Y, Timpl R: A single EGF-like motif of laminin is responsible for high affinity nidogen binding. EMBO J 12:1879-1885, 1993
90. 90. Mayer U, Poschl E, Gerecke DR, Wagman DW, Burgeson RE, Timpl R: Low nidogen affinity of laminin-5 can be attributed to two serine residues in EGF-like motif gamma 2III4. FEBS Lett 365:129-132, 1995
91. 91. Kimura N, Toyoshima T, Kojima T, Shimane M: Entactin-2: A new member of basement membrane protein with high homology to entactin/nidogen. Exp Cell Res 241:36-45, 1998
92. 92. Kohfeldt E, Sasaki T, Gohring W, Timpl R: Nidogen-2: A new basement membrane protein with diverse binding properties. J Mol Biol 282:99-109, 1998
93. 93. Timpl R: Proteoglycans of basement membranes. Experientia 49: 417-428, 1993
94. 94. Couchman JR, Kapoor R, Sthanam M, Wu R-R: Perlecan and basement membrane-chondroitin sulfate proteoglycan (Bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J Biol Chem 271:9595-9602, 1996
95. 95. Farquhar MG: The glomerular basement membrane: A selective macromolecular filter, in Cell Biology of Extracellular Matrix, edited by Hay ED, New York, Plenum Press, 1981, pp 335-378
96. 96. Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassell JR: The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 266:22939-22947, 1991
97. 97. Tsen G, Lalfter W, Kroger S, Cole GJ: Agrin is a heparan sulfate proteoglycan. J Biol Chem 270:3392-3399, 1995
98. 98. Groffen AJ, Ruegg MA, Dijkman H, van de Velden TJ, Buskens CA, van den Born J, Assmann KJ, Monnens LA, Veerkamp JH, van den Heuvel LP: Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem 46:19-27, 1998
99. 99. Groffen AJ, Buskens CA, van Kuppevelt TH, Veerkamp JH, Monnens LA, van den Heuvel LP: Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 254:123-128, 1998
100. 100. Raats CJ, Bakker MA, Hoch W, Tamboer WP, Groffen AJ, van den Heuvel LP, Berden JH, van den Born J: Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 273:17832-17838, 1998
101. 101. Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie JP, Sanes JR: Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85:525-535, 1996
102. 102. McCarthy KJ, Couchman JR: Basement membrane chondroitin sulfate proteoglycans: Localization in adult rat tissues. J Histochem Cytochem 38:1479-1486, 1990
103. 103. Wu R-R, Couchman JR: cDNA cloning of the basement membrane chondroitin sulfate proteoglycan core protein, bamacan: A five domain structure including coiled-coil motifs. J Cell Biol 136:433-444, 1997
104. 104. McCarthy KJ, Bynum K, St. John PL, Abrahamson DR, Couchman JR: Basement membrane proteoglycans in glomerular morphogenesis: Chondroitin sulfate proteoglycan is temporally and spatially restricted during development. J Histochem Cytochem 41:401-414, 1993
105. 105. Muragaki Y, Timmons S, Griffith CM, Oh SP, Fadel B, Quertermous T, Olsen BR: Mouse Coll8a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci USA 92:8763-8767, 1995
106. 106. Halfter W, Dong S, Schurer B, Cole GJ: Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 273:25404-25412, 1998
107. 107. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285, 1997
108. 108. Saxen L: Organogenesis of the Kidney. Cambridge, Cambridge University Press, 1987
109. 109. Sorokin L, Ekblom P: Development of tubular and glomerular cells of the kidney. Kidney Int 41:657-664, 1992
110. 110. Harvey SJ, Zheng K, Sado Y, Naito I, Ninomiya Y, Jacobs RM, Hudson BG, Thorner PS: Role of distinct type IV collagen networks in glomerular development and function. Kidney Int 54:1857-1866, 1998
111. 111. Kleppel MM, Michael AF: Expression of novel basement membrane components in the developing human kidney and eye. Am J Anat 187:165-174, 1990
112. 112. Kuroda N, Yoshikawa N, Nakanishi K, Iijima K, Hanioka K, Hayashi Y, Imai Y, Sado Y, Nakayama M, Itoh H: Expression of type IV collagen in the developing human kidney. Pediatr Nephrol 12:554-558, 1998
113. 113. Noakes PG, Gautam M, Mudd J, Sanes JR, Merlie JP: Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin β2. Nature 374:258-262, 1995
114. 114. Olgemoller B, Schleicher E: Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy. Clin Invest 71:S13-S19, 1993
115. 115. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744, 1993
116. 116. Adler S: Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. (editorial) J Am Soc Nephrol 5:1165-1172, 1994
117. 117. Kim Y, Butkowski R, Burke B, Kleppel MM, Crosson J, Katz A, Michael AF: Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol 139:1381-1388, 1991
118. 118. Buyukbabani N, Droz D: Distribution of the extracellular matrix components in human glomerular lesions. J Pathol 172:199-207, 1994
119. 119. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA: Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 44:211-219, 1995
120. 120. Abrass CK, Berfield AK, Stehman-Breen C, Alpers CE, Davis CL: Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies. Am J Kidney Dis 33:11-20, 1999